Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) rose 3.3% on Friday . The company traded as high as $11.60 and last traded at $11.32. Approximately 1,268,100 shares were traded during trading, an increase of 275% from the average daily volume of 337,931 shares. The stock had previously closed at $10.96.
Silverback Therapeutics Stock Down 1.2 %
The stock has a market cap of $403.13 million, a P/E ratio of -4.62 and a beta of 0.60. The firm has a 50 day simple moving average of $14.25 and a 200-day simple moving average of $12.31.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- What Are the U.K. Market Holidays? How to Invest and Trade
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What is the Dow Jones Industrial Average (DJIA)?
- CarMax Gets in Gear: Is Now the Time to Buy?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
